Bodewes, I. L. A., Gottenberg, J., van Helden-Meeuwsen, C. G., Mariette, X., & Versnel, M. A. (2020). Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial. Rheumatology (Oxford).

Bodewes, Iris L A., Jacques-Eric Gottenberg, Cornelia G. van Helden-Meeuwsen, Xavier Mariette, und Marjan A. Versnel. "Hydroxychloroquine Treatment Downregulates Systemic Interferon Activation in Primary Sjögren’s Syndrome in the JOQUER Randomized Trial." Rheumatology (Oxford) 2020.

Bodewes, Iris L A., et al. "Hydroxychloroquine Treatment Downregulates Systemic Interferon Activation in Primary Sjögren’s Syndrome in the JOQUER Randomized Trial." Rheumatology (Oxford) 2020.